Testosterone for type 2 diabetes prevention in men: A 2-year multicentre, randomised, double-blind, placebo-controlled trial

Gary Wittert; Evan Atlantis; Mathis Grossmann; Bu B. Yeap; Ann Conway; Bronwyn Stuckey; David Handelsman; Robert McLachlan; Carolyn Allan; Alicia Jenkins; Mark Daniel; Karen Bracken

Testosterone for type 2 diabetes prevention in men: A 2-year multicentre, randomised, double-blind, placebo-controlled trial

Gary Wittert, Evan Atlantis, Mathis Grossmann, Bu B. Yeap, Ann Conway, Bronwyn Stuckey, David Handelsman, Robert McLachlan, Carolyn Allan, Alicia Jenkins, Mark Daniel, Karen Bracken

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract

Original language	English
Pages (from-to)	47-48
Number of pages	2
Journal	Clinical Endocrinology
Volume	89
Publication status	Published - Jun 2018
Event	Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB) - Perth, Australia Duration: 27 Aug 2017 → 30 Aug 2017

Cite this

Wittert, G., Atlantis, E., Grossmann, M., Yeap, B. B., Conway, A., Stuckey, B., ... Bracken, K. (2018). Testosterone for type 2 diabetes prevention in men: A 2-year multicentre, randomised, double-blind, placebo-controlled trial. Clinical Endocrinology, 89, 47-48.

Wittert, Gary ; Atlantis, Evan ; Grossmann, Mathis ; Yeap, Bu B. ; Conway, Ann ; Stuckey, Bronwyn ; Handelsman, David ; McLachlan, Robert ; Allan, Carolyn ; Jenkins, Alicia ; Daniel, Mark ; Bracken, Karen. / Testosterone for type 2 diabetes prevention in men : A 2-year multicentre, randomised, double-blind, placebo-controlled trial. In: Clinical Endocrinology. 2018 ; Vol. 89. pp. 47-48.

@article{719830d3fba64ef09219809c8ce58e1b,

title = "Testosterone for type 2 diabetes prevention in men: A 2-year multicentre, randomised, double-blind, placebo-controlled trial",

author = "Gary Wittert and Evan Atlantis and Mathis Grossmann and Yeap, {Bu B.} and Ann Conway and Bronwyn Stuckey and David Handelsman and Robert McLachlan and Carolyn Allan and Alicia Jenkins and Mark Daniel and Karen Bracken",

year = "2018",

month = "6",

language = "English",

volume = "89",

pages = "47--48",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "John Wiley & Sons",

}

Testosterone for type 2 diabetes prevention in men : A 2-year multicentre, randomised, double-blind, placebo-controlled trial. / Wittert, Gary; Atlantis, Evan; Grossmann, Mathis; Yeap, Bu B.; Conway, Ann; Stuckey, Bronwyn; Handelsman, David; McLachlan, Robert; Allan, Carolyn; Jenkins, Alicia; Daniel, Mark; Bracken, Karen.

In: Clinical Endocrinology, Vol. 89, 06.2018, p. 47-48.

Research output: Contribution to journal › Abstract/Meeting Abstract

TY - JOUR

T1 - Testosterone for type 2 diabetes prevention in men

T2 - A 2-year multicentre, randomised, double-blind, placebo-controlled trial

AU - Wittert, Gary

AU - Atlantis, Evan

AU - Grossmann, Mathis

AU - Yeap, Bu B.

AU - Conway, Ann

AU - Stuckey, Bronwyn

AU - Handelsman, David

AU - McLachlan, Robert

AU - Allan, Carolyn

AU - Jenkins, Alicia

AU - Daniel, Mark

AU - Bracken, Karen

PY - 2018/6

Y1 - 2018/6

M3 - Abstract/Meeting Abstract

VL - 89

SP - 47

EP - 48

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

ER -

Grants

Testosterone Intervention for the Prevention of Diabetes Mellitus in High Risk Men - A Randomised Trial

Project: Research

Testosterone for type 2 diabetes prevention in men: A 2-year multicentre, randomised, double-blind, placebo-controlled trial

Cite this

Related content

Grants

Testosterone Intervention for the Prevention of Diabetes Mellitus in High Risk Men - A Randomised Trial